Despite a weak third quarter, the Hospital sector’s merger and acquisition activity stayed relatively consistent, with deal volume ranging between 20 and 23 deals per quarter. The fourth quarter of 2017 posted 21 transactions, accounting for 27% of the 78 announced in the prior 12 months. Deal volume was up 40% compared with the previous […]
Hospital M&A activity accelerated in the fourth quarter of 2017. The number of hospital acquisitions rose to 21 in the fourth quarter, up 40% from the 15 publicly announced acquisitions in the third quarter of 2017. Compared with the same quarter in 2016, which posted 23 transactions, activity was down 9%. None of the transactions […]
UnitedHealth Group (NYSE: UNH) wasted no time dwelling on its recent acquisition of DaVita Medical Group (NYSE: DVA) for $4.9 billion. On December 22, the healthcare giant announced its acquisition of Chilean healthcare company Banmedica SA (SSE: SGO) for $2.8 billion. Banmeica sells health insurance, operates hospitals and provides other services. It generated approximately $2.1 […]
Kidney care specialist DaVita (NYSE: DVA) made good on its statement that it was exploring strategic alternatives for its DaVita Medical Group (DMG). It found a buyer in UnitedHealth Group’s (NYSE: UNH) Optum, which agreed to pay $4.9 billion for DMG, the highest publicly announced price it has paid for a physician group.
Investors have flocked to the “Other Services” sector this year, as its ancillary nature keeps the companies that comprise it largely outside the purview of reimbursement regulations and other stroke-of-the-pen sectors.
Centene Corporation (NYSE: CNC), the self-declared leader in government-sponsored healthcare in the U.S., has taken over another state. As larger rivals like Anthem (NYSE: ANTM) and UnitedHealth Group (NYSE: UNH) quit the individual health insurance exchanges around the country, Centene has marched in. In its first major deal since July 2015, Centene is now tops […]
Drug companies and managed care organizations are working to keep prices from rising precipitously. Then there’s Pfizer.
Now that managed care giants are blocked from acquiring each other, they may look outside the sector for growth.
The annual ACG NYC healthcare conference sought to make sense of what the Trump administration is going to do to the Affordable Care Act. A reporter shares her notes.
Healthcare deal volume got off to a good start in 2017 as January’s total reached 156 transactions.